A number of recent studies have verified that therapeutic strategies involving IL-6 inhibitors and TNFα inhibitors result in a decrease of serum SAA level and consequently represent an excellent therapeutic strategy for AA amyloidosis. Here, SAA1 is linked to AA amyloidosis.